Diabetes Infographic: Real-time Patient Insights from Medisafe

5 Sep 2019

Highlights from the Diabetes Infographic

  • The frequency of dosing schedules in both the GLP-1 class and Insulin impacts the rate of adherence
  • 71% of Medisafe users improved their adherence after adding a Medisafe Medfriend who is alerted each time a dose is missed
  • 17% improvement of average reported adherence rate a after adding a Medifriend


What insights can we discover about your brand? Contact us to find out!


Full Diabetes Adherence Insights

Reported Diabetes Drug Adherence by Drug & Dose

  • GLP-1, 1x/week: 88%
  • GLP-1, 1x/day: 80%
  • GLP-1, 2x/day: 77%
  • Insulin, Long-acting 1-2x/day: 79%
  • Insulin, Intermediate-acting 1-2x/day: 78%
  • Insulin, Short-acting 2-3x/day: 73%
  • Insulin, Rapid-acting 3x/day: 73%

Injectables versus Orals

  • All GLP-1 and insulin injectables: 76%
  • All oral diabetic meds: 74%

What insights can we discover about your brand? Contact us to find out!

You may also like

Infographics

Medisafe’s Digital Companion Launch Toolkit

This free launch toolkit has the must-have answers and best practices for all eight stages of a successful digital  launch. 

..Read More
Infographics

Digital health increases pharma’s engagement with patients

Discover how new technologies are driving the growth of digital health companions, and how these tools are advancing pharma.

..Read More
Infographics

Neurology Infographic: Real-time Patient Insights from Medisafe

Highlights from the Neurology Infographic The U.S. trails other nations in reported neuro medication adherence on Medisafe Like many therapeutic 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.